Clinical Trial Update: Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011)

View source ↗

Summary

This is a completed post-marketing observational study evaluating retreatment of chronic hepatitis C with peginterferon alfa and ribavirin; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (peginterferon alfa-2a) (peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Status: COMPLETED | Results posted: 2012-11-20